Page last updated: 2024-08-25

lead and lassbio-579

lead has been researched along with lassbio-579 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrade, CH; Antonio, CB; Barreiro, EJ; Betti, AH; Dalla Costa, T; de Oliveira, V; Fraga, CA; Gil, ES; Gomes, TF; Menegatti, R; Noël, F; Pompeu, TE; Rates, SM; Rodrigues, DA; Sabino, JR	1

Other Studies

1 other study(ies) available for lead and lassbio-579

Article	Year
Biotransformation of LASSBio-579 and pharmacological evaluation of p-hydroxylated metabolite a N-phenylpiperazine antipsychotic lead compound. European journal of medicinal chemistry, 2013, Volume: 62 Topics: Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Lead; Male; Models, Molecular; Molecular Dynamics Simulation; Molecular Structure; Organometallic Compounds; Piperazines; Rats; Rats, Wistar; Receptors, Dopamine D4; Structure-Activity Relationship	2013

Article

Year

Biotransformation of LASSBio-579 and pharmacological evaluation of p-hydroxylated metabolite a N-phenylpiperazine antipsychotic lead compound.

European journal of medicinal chemistry, 2013, Volume: 62

Topics: Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Lead; Male; Models, Molecular; Molecular Dynamics Simulation; Molecular Structure; Organometallic Compounds; Piperazines; Rats; Rats, Wistar; Receptors, Dopamine D4; Structure-Activity Relationship

2013